“The dirty little secret is that PBMs—once seen as the key to controlling drug costs—are actually driving them up for everyone. As we begin to focus on the cost of drugs, part of the conversation must be DIR fees, another example of a made-up, contrived tool used by PBMs to feed profits at the expense of patients, the Medicare program, and Pharmacy Providers. President Trump has vowed to tackle prescription drug costs—a good place to start is looking at what the PBMs are doing to fuel those costs.”

Ted Okon, Executive Director
Community Oncology Alliance (COA)